Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.

Sahin IH, Elias H, Chou JF, Capanu M, O'Reilly EM.

BMC Cancer. 2018 Jul 28;18(1):769. doi: 10.1186/s12885-018-4679-9.

2.

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

Hu ZI, Shia J, Stadler ZK, Varghese AM, Capanu M, Salo-Mullen E, Lowery MA, Diaz LA Jr, Mandelker D, Yu KH, Zervoudakis A, Kelsen DP, Iacobuzio-Donahue CA, Klimstra DS, Saltz LB, Sahin IH, O'Reilly EM.

Clin Cancer Res. 2018 Mar 15;24(6):1326-1336. doi: 10.1158/1078-0432.CCR-17-3099. Epub 2018 Jan 24.

PMID:
29367431
3.

Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?

Sahin IH, Askan G, Hu ZI, O'Reilly EM.

Ann Oncol. 2017 Dec 1;28(12):2950-2961. doi: 10.1093/annonc/mdx503. Review.

PMID:
28945842
4.
5.

Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.

Sahin IH, Lowery MA, Stadler ZK, Salo-Mullen E, Iacobuzio-Donahue CA, Kelsen DP, O'Reilly EM.

Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):893-905. doi: 10.1586/17474124.2016.1153424. Epub 2016 Feb 26. Review.

6.

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.

Sahin IH, Iacobuzio-Donahue CA, O'Reilly EM.

Expert Opin Ther Targets. 2016;20(3):341-59. doi: 10.1517/14728222.2016.1094057. Epub 2015 Oct 6. Review.

7.

Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications.

Sahin IH, Geyer AI, Kelly DW, O'Reilly EM.

Clin Colorectal Cancer. 2016 Mar;15(1):24-31. doi: 10.1016/j.clcc.2015.08.003. Epub 2015 Aug 22.

8.

CD44 as a drug delivery target in human cancers: where are we now?

Sahin IH, Klostergaard J.

Expert Opin Ther Targets. 2015;19(12):1587-91. doi: 10.1517/14728222.2015.1088834. Epub 2015 Sep 16.

PMID:
26374284
9.

Comment on: α-smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study.

Sahin IH, Uzunparmak B.

Br J Cancer. 2015 May 26;112(11):1838. doi: 10.1038/bjc.2014.663. Epub 2015 Jan 20. No abstract available.

10.

High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study.

Tanasanvimon S, Garg N, Viswanathan C, Truong M, Kaur H, Kee BK, Sahin IH, Javle MM, Garrett CR.

Thromb Res. 2014 Feb;133(2):154-7. doi: 10.1016/j.thromres.2013.10.027. Epub 2013 Oct 24.

PMID:
24331209
11.

Re: Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.

Oktay AA, Alpay SN, Sahin IH.

J Natl Cancer Inst. 2013 Dec 4;105(23):1837. doi: 10.1093/jnci/djt307. Epub 2013 Oct 29. No abstract available.

PMID:
24168969
12.

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM.

Oncology. 2013;85(4):197-203. doi: 10.1159/000354698. Epub 2013 Sep 19.

13.

Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.

Sahin IH, Hassan MM, Garrett CR.

Cancer Lett. 2014 Apr 10;345(2):249-57. doi: 10.1016/j.canlet.2013.09.001. Epub 2013 Sep 7. Review.

PMID:
24021750
14.

Obesity, bisphosphonates, and colorectal cancer.

Sahin IH.

J Clin Oncol. 2013 Jul 10;31(20):2639. doi: 10.1200/JCO.2013.49.6000. Epub 2013 May 28. No abstract available.

PMID:
23715564
15.

Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.

Sahin IH, Kazmi SM, Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR.

J Cancer. 2013;4(4):320-2. doi: 10.7150/jca.3619. Epub 2013 Mar 28.

16.

The impact of aspirin use on colorectal cancer patients.

Sahin IH.

Eur J Cancer. 2013 Jun;49(9):2274-5. doi: 10.1016/j.ejca.2013.02.040. Epub 2013 Mar 28. No abstract available.

PMID:
23541569
17.

EGFR signalling and oncogenic pathway signature in colorectal cancer.

Sahin IH, Oktay AA.

Gut. 2013 Nov;62(11):1670. doi: 10.1136/gutjnl-2013-304781. Epub 2013 Mar 26. No abstract available.

PMID:
23532175
18.

Association of diabetes and perineural invasion in pancreatic cancer.

Sahin IH, Shama MA, Tanaka M, Abbruzzese JL, Curley SA, Hassan M, Li D.

Cancer Med. 2012 Dec;1(3):357-62. doi: 10.1002/cam4.43. Epub 2012 Oct 30.

19.

Aspirin, PIK3CA mutation, and colorectal-cancer survival.

Sahin IH, Garrett C.

N Engl J Med. 2013 Jan 17;368(3):289. doi: 10.1056/NEJMc1214189. No abstract available.

PMID:
23323915
20.

[Malaria epidemiology in Bitlis from 1998 to 2008].

Sahin IH, Zeyrek FY, Aydın MF, Öntürk H, Basank M.

Turkiye Parazitol Derg. 2012;36(1):1-3. doi: 10.5152/tpd.2012.01. Turkish.

Supplemental Content

Loading ...
Support Center